Literature DB >> 19329922

Results of open heart surgery in Jehovah's Witnesses patients.

A Juraszek1, T Dziodzio, S Roedler, A Kral, D Hutschala, E Wolner, M Grimm, M Czerny.   

Abstract

AIM: The aim of this paper was to evaluate the results in patients from the religious community of Jehovah's Witnesses (JW) undergoing open heart surgery.
METHODS: Between January 1998 and November 2007, 35 patients with a religious background of JW church underwent open heart surgery at the Department of Cardiothoracic Surgery, Medical University of Vienna (Austria). Eighteen patients underwent coronary artery bypass graft (CABG), 11 patients underwent valve surgery and 5 patients underwent combined procedures. One patient underwent isolated ascending aortic replacement. Five patients undergoing CABG were operated without cardiopulmonary bypass (CBP).
RESULTS: Mean baseline hematocrit serum levels were 35.8+/-6.3%. The mean decrease of hematocrit serum levels was 20.0+/-21.1% after surgery. The mean decrease of hematocrit serum levels in patients undergoing CABG without CPB was 12.5+/-5.4% and 12.0+/-20.0% in patients after isolated valve replacement. One patient died during the operation. Four patients died in the postoperative period due to anemia. During follow-up, being 34.6+/-34.8 months to date, no cardiovascular related adverse event has been observed.
CONCLUSIONS: The decrease of hematocrit serum levels is significantly characterizing the postoperative period of open heart surgery in JW. In patients undergoing CABG without CPB and in patients undergoing isolated valve replacement, decrease of hematocrit serum levels was lowest. Therefore, these techniques should be considered for first choice when appropriate. Furthermore, highly normal preoperative hematocrit serum levels and a meticulous surgical technique remain the mainstay of therapy in these patients.

Entities:  

Mesh:

Year:  2009        PMID: 19329922

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  4 in total

1.  Risk-adjusted clinical outcomes in patients enrolled in a bloodless program.

Authors:  Steven M Frank; Elizabeth C Wick; Amy E Dezern; Paul M Ness; Jack O Wasey; Andrew C Pippa; Elizabeth Dackiw; Linda M S Resar
Journal:  Transfusion       Date:  2014-06-18       Impact factor: 3.157

2.  Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients: 21 year experience.

Authors:  Claude D Vaislic; Nicolas Dalibon; Oliver Ponzio; Maguette Ba; Eric Jugan; Franck Lagneau; Philippe Abbas; Yves Olliver; Didier Gaillard; Francois Baget; Michel Sportiche; Antoine Chedid; Georges Chaoul; Philippe Maribas; Christiane Dupuy; Bruno Robine; Nicolas Kasanin; Herve Michon; Jean-Michel Ruat; Michel Habis; Touhami Bouharaoua
Journal:  J Cardiothorac Surg       Date:  2012-09-27       Impact factor: 1.637

3.  Results of open heart surgery in Jehovah's Witness patients. Single centre experience.

Authors:  Andrzej Juraszek; Piotr Kołsut; Jarosław Szymański; Jarosław Kuriata; Krzysztof Kuśmierski; Ewa Sitkowska-Rysiak; Małgorzata Jasińska; Mariusz Kuśmierczyk
Journal:  Kardiochir Torakochirurgia Pol       Date:  2017-09-30

4.  Transfusion of blood products in off-pump coronary artery bypass and conventional coronary artery revascularization. A prospective randomized study.

Authors:  Maciej Walczak; Tomasz Kamil Urbanowicz; Jadwiga Tomczyk; Estillita Camacho; Marcin Ligowski; Sebastian Stefaniak; Marek Jemielity
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.